(NJAN) Innovator Nasdaq-100 Power - Ratings and Ratios

Exchange: BATS • Country: USA • Currency: USD • Type: Etf • • Defined Outcome

NJAN: Options, ETFs

The Innovator Nasdaq-100 Power Buffer ETF - January (BATS:NJAN) is a non-diversified exchange-traded fund (ETF) designed to provide investors with exposure to the performance of the Nasdaq-100 Index, with a focus on risk management. The fund primarily invests at least 80% of its net assets in FLexible Exchange® Options (FLEX Options) that reference the Invesco QQQ TrustSM, series 1 (QQQ), which tracks the Nasdaq-100 Index. These FLEX Options are customizable exchange-traded option contracts that allow the fund to tailor its exposure to the underlying index. The ETF employs a defined outcome strategy, aiming to provide a power buffer against potential losses while participating in the upside of the Nasdaq-100 Index, up to a predetermined cap.

FLEX Options are unique in that they can be structured with specific terms, such as expiration dates and strike price levels, which are not typically found in standard exchange-listed options. This flexibility allows the fund to implement a buffer strategy, designed to limit losses in declining markets while still offering potential for growth in rising markets. The funds use of options allows it to seek a specific outcome within a defined time frame, making it a tool for investors seeking a combination of growth and risk mitigation.

As of the latest data, the fund has an average trading volume of 53,214 shares over the past 20 days, with a last price of $48.26. Its moving averages are $48.89 (SMA 20), $48.52 (SMA 50), and $46.55 (SMA 200), indicating a recent uptrend. The Average True Range (ATR) of 0.37 suggests relatively low volatility. The fund has assets under management (AUM) of $312.36 million, reflecting its scale in the defined outcome ETF category.

Based on and , the fund is expected to trade within a range of $47.50 to $49.50 over the next three months. The SMA 20 and SMA 50 are converging, suggesting potential consolidation. With an ATR of 0.37, daily price movements are likely to remain moderate. The AUM of $312.36 million indicates sufficient liquidity to support consistent trading activity. The funds defined outcome strategy will likely cap upside participation at 10-15% while maintaining a buffer against declines of up to 10%.

Additional Sources for NJAN ETF

NJAN ETF Overview

Market Cap in USD 324m
Category Defined Outcome
TER 0.79%
IPO / Inception 2019-12-31

NJAN ETF Ratings

Growth 5y 64.8%
Fundamental -
Dividend 0.0%
Rel. Strength Industry -0.33
Analysts -
Fair Price Momentum 44.60 USD
Fair Price DCF -

NJAN Dividends

No Dividends Paid

NJAN Growth Ratios

Growth Correlation 3m 9.5%
Growth Correlation 12m 94.2%
Growth Correlation 5y 67.1%
CAGR 5y 8.47%
CAGR/Max DD 5y 0.41
Sharpe Ratio 12m 1.53
Alpha 0.29
Beta 0.54
Volatility 18.74%
Current Volume 32.2k
Average Volume 20d 35.5k
What is the price of NJAN stocks?
As of March 14, 2025, the stock is trading at USD 46.12 with a total of 32,156 shares traded.
Over the past week, the price has changed by -2.29%, over one month by -6.53%, over three months by -3.71% and over the past year by +6.66%.
Is Innovator Nasdaq-100 Power a good stock to buy?
Yes. Based on ValueRay Analyses, Innovator Nasdaq-100 Power (BATS:NJAN) is currently (March 2025) a good stock to buy. It has a ValueRay Growth Rating of 64.79 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NJAN as of March 2025 is 44.60. This means that NJAN is currently overvalued and has a potential downside of -3.3%.
Is NJAN a buy, sell or hold?
Innovator Nasdaq-100 Power has no consensus analysts rating.
What are the forecast for NJAN stock price target?
According to ValueRays Forecast Model, NJAN Innovator Nasdaq-100 Power will be worth about 48.9 in March 2026. The stock is currently trading at 46.12. This means that the stock has a potential upside of +5.96%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 48.9 6%